FA, A., C, B., A, B., T, Z., T, S., K, R., . . . B, F. (2021). Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting. Blood advances, 5(11), 2523. https://doi.org/10.1182/bloodadvances.2020003959
Chicago Style (17th ed.) CitationFA, Ayuk, et al. "Axicabtagene Ciloleucel in Vivo Expansion and Treatment Outcome in Aggressive B-cell Lymphoma in a Real-world Setting." Blood Advances 5, no. 11 (2021): 2523. https://doi.org/10.1182/bloodadvances.2020003959.
MLA (9th ed.) CitationFA, Ayuk, et al. "Axicabtagene Ciloleucel in Vivo Expansion and Treatment Outcome in Aggressive B-cell Lymphoma in a Real-world Setting." Blood Advances, vol. 5, no. 11, 2021, p. 2523, https://doi.org/10.1182/bloodadvances.2020003959.